Study finds 4 drugs have little to no effect on COVID-19

Share on facebook
Share on twitter
Share on linkedin
Share on reddit



GENEVA (AP) — The world’s largest randomized trial of COVID-19 treatments found “conclusive evidence” that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has little or no effect on severe cases, the U.N. health agency said Friday.

The World Health Organization announced the long-awaited results of a six-month trial that endeavored to see if existing drugs might have an effect on the coronavirus.

The study, which was not peer-reviewed, found that four treatments tested — remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon — had ” little or no effect” on whether or not patients died within about a month or whether hospitalized patients recovered.

Most of those had already been ruled out. But remdesivir, an antiviral, has been classified as standard-of-care in the United States, and it has been approved for use against COVID-19 in the UK and EU. Supplies of the drug have been limited, and the European Medicines Agency is now reviewing whether remdesivir is causing kidney problems as reported by some patients.

The results of the global trial are in sharp contrast to a large study in the United States, which found remdesivir…



Comments

Leave a Reply

Responses

Sign up for our Daily News Briefing

Get daily news delivered to your inbox. 

Build for us, by us...

Social Community

Breaking News

Business Directory

Connections

Grow

Forge Your Kingdom...

Community is Everything: Build a tribe of inspiring friends. Build a community, of like-minds, who will give you the strength to act on your ideas and inspire you to be the best version of you.

Community

Connect, Share, & Grow! Share your stories!

Mobile Friendly

Access the community from any device.

Buy Black

Thousands of minority-owned businesses at your fingertips.